Beacon Financial Group Sells 12,017 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Beacon Financial Group lowered its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 46.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 13,756 shares of the pharmacy operator’s stock after selling 12,017 shares during the period. Beacon Financial Group’s holdings in Walgreens Boots Alliance were worth $128,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. State Street Corp increased its holdings in Walgreens Boots Alliance by 18.0% in the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock valued at $385,258,000 after buying an additional 6,569,223 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in shares of Walgreens Boots Alliance by 43.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after acquiring an additional 3,329,857 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Walgreens Boots Alliance by 12.1% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock worth $68,046,000 after acquiring an additional 817,762 shares in the last quarter. Thompson Siegel & Walmsley LLC increased its stake in Walgreens Boots Alliance by 15.5% in the third quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock valued at $62,325,000 after acquiring an additional 934,754 shares during the last quarter. Finally, FMR LLC raised its position in Walgreens Boots Alliance by 2.5% during the third quarter. FMR LLC now owns 3,258,919 shares of the pharmacy operator’s stock valued at $29,200,000 after purchasing an additional 80,525 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have weighed in on WBA. UBS Group raised their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. Barclays raised their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. Truist Financial reduced their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research report on Friday, January 31st. Evercore ISI upped their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. Finally, Bank of America lifted their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $13.19.

Walgreens Boots Alliance Trading Up 1.2 %

Shares of WBA opened at $9.47 on Thursday. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The firm’s fifty day simple moving average is $10.25 and its two-hundred day simple moving average is $9.77. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $22.55.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.66 EPS. Equities analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.